ArticleFrontiers in oncology2022

Metabolic syndrome is a risk factor for breast cancer patients receiving neoadjuvant chemotherapy: A case-control study.

Zhaoyue Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.